Heinz Ludwig, MD, PhD, from Wilhelminen Cancer Research Institute, Vienna, Austria, discusses treatment sequencing in multiple myeloma (MM). Dr Ludwig covers the many options available to treat MM, particularly when options are restricted in cases of drug resistance and relapse. This interview took place at the European School of Haematology (ESH) International Conference on MM 2018, held in Mandelieu, France.
Treatment sequencing in multiple myeloma: a multitude of options
